SUN PHARMACEUTICALSUN PHARMACEUTICALSUN PHARMACEUTICAL

SUN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪3.69 T‬INR
‪84.74 B‬INR
‪438.86 B‬INR
‪1.02 B‬
Beta (1Y)
0.58

About SUN PHARMACEUTICAL

CEO
Dilip Shantilal Shanghvi
Headquarters
Mumbai
Employees (FY)
‪24.77 K‬
Founded
1983
ISIN
INE044A01036
FIGI
BBG000BV5H87
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where SUNPHARMA is featured.

Frequently Asked Questions

The current price of SUNPHARMA is 1516.40 INR — it has decreased by 1.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUN PHARMACEUTICAL stocks are traded under the ticker SUNPHARMA.
SUN PHARMACEUTICAL is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
SUNPHARMA stock is 2.60% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is SUN PHARMACEUTICAL there?
One year price forecast for SUN PHARMACEUTICAL has a max estimate of 1827.00 INR and a min estimate of 1200.00 INR.
SUNPHARMA earnings for the last quarter are 9.90 INR whereas the estimation was 8.98 INR which accounts for 10.24% surprise. Estimated earnings for the next quarter are 9.95 INR. See more details about SUN PHARMACEUTICAL earnings.
SUN PHARMACEUTICAL revenue for the last quarter amounts to ‪121.92 B‬ INR despite the estimated figure of ‪120.69 B‬ INR. In the next quarter revenue is expected to reach ‪122.79 B‬ INR.
Yes, you can track SUN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
SUNPHARMA stock has fallen by 5.41% compared to the previous week, the month change is a 3.66% fall, over the last year SUN PHARMACEUTICAL has showed a 51.11% increase.
SUNPHARMA net income for the last quarter is ‪25.24 B‬ INR, while the quarter before that showed ‪23.76 B‬ INR of net income which accounts for 6.24% change. Track more SUN PHARMACEUTICAL financial stats to get the full picture.
Today SUN PHARMACEUTICAL has the market capitalization of ‪3.69 T‬, it has decreased by 1.38% over the last week.
SUN PHARMACEUTICAL dividend yield was 1.17% in 2022, and payout ratio reached 32.56%. The year before the numbers were 1.09% and 73.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SUNPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
SUNPHARMA reached its all-time high on Apr 5, 2024 with the price of 1638.85 INR, and its all-time low was 6.75 INR and was reached on Jan 1, 1999.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪24.77 K‬ employees. See our rating of the largest employees — is SUN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMACEUTICAL stock shows the buy signal. See more of SUN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SUN PHARMACEUTICAL future price: according to them, SUNPHARMA price has a max estimate of 1827.00 INR and a min estimate of 1200.00 INR. Read a more detailed SUN PHARMACEUTICAL forecast: see what analysts think of SUN PHARMACEUTICAL and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMACEUTICAL EBITDA is ‪127.25 B‬ INR, and current EBITDA margin is 26.52%. See more stats in SUN PHARMACEUTICAL financial statements.